The Weight-Loss Drug Boom: Profit Over Ethics? [5jOzDF_tUt_]

The Weight-Loss Drug Boom: Profit Over Ethics? [5jOzDF_tUt_]

| 1h 28m 28s | Video has closed captioning.

The Weight-Loss Drug Boom: Profit Over Ethics? Weight-loss drugs like Wegovy and Mounjaro are under scrutiny as pharmacies ramp up their marketing efforts with aggressive discounts and promotional strategies that raise ethical concerns. Pharmacies, from Boots to Pharmacy2U, are promoting these prescription-only medications heavily, a notable divergence from how other medical products are marketed online. With obesity affecting 60% of the UK population, demand for these medications is surging, resulting in massive revenues for pharmacies that could reach hundreds of thousands of pounds annually. However, this boom is not solely driven by pharmaceutical companies. Experts warn that the relationship between pharmacies, marketing practices, and public health raises questions about the regulation of such promotional activities. Critics argue that these strategies could normalize the use of weight-loss medications without proper consideration of their implications, ultimately leading to a harmful cycle of dependence and commercialization of health. #BreakingNews #DailyNews #WeightLossDrugs #PharmacyEthics #HealthMarketing #diet pill store #speed in diet pills